Advertisement
AMS vs EFFE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMS is a Hold and EFFE is a Hold.
Momentum Indicator for AMS turns negative, indicating new downward trend
AMS saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 135 similar instances where the indicator turned negative. In 99 of the 135 cases, the stock moved further down in the following days. The odds of a decline are at 73%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for AMS turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 33 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
AMS moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for AMS entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AMS's RSI Oscillator exited the oversold zone, 8 of 9 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMS advanced for three days, in 133 of 205 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
AMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.368) is normal, around the industry mean (204.058). P/E Ratio (-4.923) is within average values for comparable stocks, (19.472). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (2.498). Dividend Yield (0.148) settles around the average of (0.099) among similar stocks. P/S Ratio (0.313) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. AMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
EFFE in downward trend: price dove below 50-day moving average on October 13, 2026
EFFE moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 4 of 5 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 80%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EFFE as a result. In 7 of 12 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.
The Moving Average Convergence Divergence Histogram (MACD) for EFFE turned negative on September 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 10 similar instances when the indicator turned negative. In 4 of the 10 cases the stock turned lower in the days that followed. This puts the odds of success at 40%.
The Aroon Indicator for EFFE entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
EFFE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
AMS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 93 | |
PRICE GROWTH RATING 1..100 | 76 | |
P/E GROWTH RATING 1..100 | 26 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AMS | EFFE | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 89% | 4 days ago 80% |
| Stochastic ODDS (%) | 4 days ago 73% | 4 days ago 73% |
| Momentum ODDS (%) | 4 days ago 73% | 4 days ago 58% |
| MACD ODDS (%) | 4 days ago 73% | 4 days ago 40% |
| TrendWeek ODDS (%) | 4 days ago 62% | 4 days ago 40% |
| TrendMonth ODDS (%) | 4 days ago 65% | 4 days ago 33% |
| Advances ODDS (%) | 21 days ago 65% | N/A |
| Declines ODDS (%) | 8 days ago 64% | N/A |
| BollingerBands ODDS (%) | 4 days ago 78% | 4 days ago 90% |
| Aroon ODDS (%) | 4 days ago 68% | 4 days ago 4% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMS’s FA Score shows that 2 FA rating(s) are green while .
- AMS’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMS’s TA Score shows that 4 TA indicator(s) are bullish.
- AMS’s TA Score: 4 bullish, 4 bearish.
Price Growth
AMS (@Hospital/Nursing Management) experienced а -0.42% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -1.36%. For the same industry, the average monthly price growth was -6.61%, and the average quarterly price growth was +16.44%.
Reported Earning Dates
AMS is expected to report earnings on Nov 18, 2026.
Industries' Descriptions
@Hospital/Nursing Management (-1.36% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
AMS and
Correlation & Price change
A.I.dvisor tells us that AMS and BKD have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMS and BKD's prices will move in lockstep.
| Ticker / NAME | Correlation To AMS | 1D Price Change % | ||
|---|---|---|---|---|
| AMS | 100% | -1.20% | ||
| BKD - AMS | 23% Poorly correlated | -2.28% | ||
| PNTG - AMS | 21% Poorly correlated | -2.89% | ||
| ADUS - AMS | 15% Poorly correlated | -0.71% | ||
| HCA - AMS | 14% Poorly correlated | -0.86% | ||
| THC - AMS | 11% Poorly correlated | -0.32% | ||
More | ||||
EFFE and
Correlation & Price change
A.I.dvisor tells us that EFFE and IBN have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EFFE and IBN's prices will move in lockstep.
| Ticker / NAME | Correlation To EFFE | 1D Price Change % | ||
|---|---|---|---|---|
| EFFE | 100% | -0.26% | ||
| IBN - EFFE | 15% Poorly correlated | -1.70% | ||
| AMS - EFFE | 12% Poorly correlated | -1.20% | ||
| HDB - EFFE | 10% Poorly correlated | -3.19% | ||
| TME - EFFE | 7% Poorly correlated | +0.46% | ||
| BID - EFFE | 2% Poorly correlated | -0.10% | ||
More | ||||